CLINICAL RESPONSE OF PATIENTS ON TOPICAL RUXOLITINIB FOR ACUTE AND CHRONIC GVHD

被引：0
|
作者：
Hudda, Zahra [1 ]
Flannery, Amanda [1 ]
Teusink-Cross, Ashley [1 ]
Khandelwal, Pooja [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S203 / S204
页数：2
相关论文
共 50 条
  • [21] Chronic Gvhd Following Steroid Sensitive, Dependent, and Refractory Acute Gvhd: Incidence and Clinical Outcomes
    Herzog, Shannon
    Weisdorf, Daniel J.
    Shanley, Ryan
    MacMillan, Margaret L.
    Holtan, Shernan G.
    El Jurdi, Najla
    BLOOD, 2022, 140 : 10493 - 10494
  • [22] Multicenter, Retrospective Evaluation of Therapeutic Efficacy of Ruxolitinib for Chronic Gvhd Treatment
    White, Jennifer
    Hamad, Nada
    Linn, Swe Mar
    Novitzky-Basso, Igor Nicolas
    Abduljalil, Omar
    Law, Arjun
    Kim, Dennis Dong Hwan
    BLOOD, 2020, 136
  • [23] Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (04) : 9 - 10
  • [24] Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults
    Wang, YunZu Michele
    Teusink-Cross, Ashley
    Elborai, Yasser
    Krupski, M. Christa
    Nelson, Adam S.
    Grimley, Michael S.
    Flannery, Amanda
    Mehta, Parinda A.
    Bleesing, Jacob J.
    Chandra, Sharat
    Kumar, Ashish R.
    Myers, Kasiani C.
    Davies, Stella M.
    Khandelwal, Pooja
    TRANSPLANTATION, 2022, 106 (02) : 412 - 419
  • [25] Pediatric acute GVHD: clinical phenotype and response to upfront steroids
    MacMillan, Margaret L.
    Holtan, Shernan G.
    Rashidi, Armin
    DeFor, Todd E.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    BONE MARROW TRANSPLANTATION, 2020, 55 (01) : 165 - 171
  • [26] Pediatric acute GVHD: clinical phenotype and response to upfront steroids
    Margaret L. MacMillan
    Shernan G. Holtan
    Armin Rashidi
    Todd E. DeFor
    Bruce R. Blazar
    Daniel J. Weisdorf
    Bone Marrow Transplantation, 2020, 55 : 165 - 171
  • [27] Consensus Conference on Clinical Practice in Chronic Graft-versus-Host Disease (GVHD): First-Line and Topical Treatment of Chronic GVHD
    Wolff, Daniel
    Gerbitz, Armin
    Ayuk, Francis
    Kiani, Alexander
    Hildebrandt, Gerhard C.
    Vogelsang, Georgia B.
    Elad, Sharon
    Lawitschka, Anita
    Socie, Gerard
    Pavletic, Steven Z.
    Holler, Ernst
    Greinix, Hildegard
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (12) : 1611 - 1628
  • [28] Ruxolitinib in children with steroid-refractory severe acute enteral GvHD
    Bleeke, M.
    Schrum, J.
    Winkler, B.
    Hartz, B.
    Mueller, I.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S230 - S230
  • [29] Retrospective study of Ruxolitinib compassionate use for acute, chronic and overlap graft-versus-host disease (GVHD), including donor lymphocyte induced GVHD
    Loisl, R.
    Clausen, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 232 - 232
  • [30] Corticosteroid replacement by ruxolitinib in patients with acute GVHD experiencing severe steroid-induced side effects
    Elizabeth A. de Kort
    Suzanne van Dorp
    Nicole M. A. Blijlevens
    Walter J. F. M. van der Velden
    Bone Marrow Transplantation, 2020, 55 : 253 - 255
12345